Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Giuliani

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis and Related Disorders|August 21, 2025
Serum neurofilament light chain as a biomarker in multiple sclerosis: A cross-sectional observation in real-world clinical practiceSaswat Sahoo, Catherine Harper, Albert K Y Tsui, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2011
Granule-derived granzyme B mediates the vulnerability of human neurons to T cell-induced neurotoxicityYohannes Haile, Katia Carmine Simmen, Dion Pasichnyk, et al.
Neurodegenerative Disease Management|November 27, 2019
Diagnosis and management of secondary-progressive multiple sclerosis: time for changeJiwon Oh, Katayoun Alikhani, Tania Bruno, et al.
Plos One|March 20, 2015
Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytesYohannes Haile, Maryam Nakhaei-Nejad, Paul A Boakye, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern ItalyMaria Trojano, Maria Liguori, Damiano Paolicelli, et al.
Nature Medicine|September 11, 2007
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammationHania Kebir, Katharina Kreymborg, Igal Ifergan, et al.
Annals of Neurology|March 29, 2002
Age-related disability in multiple sclerosisMaria Trojano, Maria Liguori, Giovanni Bosco Zimatore, et al.
Bioactive Materials|November 4, 2022
Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathologyBibin Anand, Qi Wu, Maryam Nakhaei-Nejad, et al.
The European Journal of Neuroscience|September 9, 2022
Astrocytes show increased levels of Ero1α in multiple sclerosis and its experimental autoimmune encephalomyelitis animal modelSamira Samtleben, Lucas Mina, Megan C Yap, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 14, 2020
Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group RecommendationsMark S Freedman, Virginia Devonshire, Pierre Duquette, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis and Related Disorders|August 21, 2025
Serum neurofilament light chain as a biomarker in multiple sclerosis: A cross-sectional observation in real-world clinical practiceSaswat Sahoo, Catherine Harper, Albert K Y Tsui, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2011
Granule-derived granzyme B mediates the vulnerability of human neurons to T cell-induced neurotoxicityYohannes Haile, Katia Carmine Simmen, Dion Pasichnyk, et al.
Neurodegenerative Disease Management|November 27, 2019
Diagnosis and management of secondary-progressive multiple sclerosis: time for changeJiwon Oh, Katayoun Alikhani, Tania Bruno, et al.
Plos One|March 20, 2015
Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytesYohannes Haile, Maryam Nakhaei-Nejad, Paul A Boakye, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern ItalyMaria Trojano, Maria Liguori, Damiano Paolicelli, et al.
Nature Medicine|September 11, 2007
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammationHania Kebir, Katharina Kreymborg, Igal Ifergan, et al.
Annals of Neurology|March 29, 2002
Age-related disability in multiple sclerosisMaria Trojano, Maria Liguori, Giovanni Bosco Zimatore, et al.
Bioactive Materials|November 4, 2022
Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathologyBibin Anand, Qi Wu, Maryam Nakhaei-Nejad, et al.
The European Journal of Neuroscience|September 9, 2022
Astrocytes show increased levels of Ero1α in multiple sclerosis and its experimental autoimmune encephalomyelitis animal modelSamira Samtleben, Lucas Mina, Megan C Yap, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 14, 2020
Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group RecommendationsMark S Freedman, Virginia Devonshire, Pierre Duquette, et al.
Pageof 6